Literature DB >> 18537055

Diabetes increases large artery diseases, but not small artery diseases in the brain.

Beom Joon Kim1, Seung-Hoon Lee, Bong Su Kang, Byung-Woo Yoon, Jae-Kyu Roh.   

Abstract

BACKGROUND: It is established that diabetes causes various systemic micro- and macro-vascular complications. Little has been, however, studied on the differential effects of diabetes on the large artery diseases (LAD) or small artery disease (SAD) in the brain. The purpose of this study was to examine an association of diabetes on the incidence of underlying LAD versus SAD in ischemic stroke patients.
METHODS: We prospectively collected 523 acute ischemic stroke patients without cardioembolic causes or other determined causes of stroke. Using brain MRI, the cerebral LAD (extracranial and intracranial arterial stenosis of 50 % or more) and the cerebral SAD (old lacunar infarction, microbleeds and leukoaraiosis) findings were assessed. Information regarding vascular risk factor was also collected.
RESULTS: Among the patients (male, n = 342; diabetes, n = 200), diabetes was not associated with the presence of LADs or SADs in female subjects, but strongly with the presence of intracranial LAD in male subjects (p < 0.01). The association remained significant (OR 2.09, 95 %CI 1.25-3.51) after adjusting for major confounders. A similar association was also found in intracranial LAD and insulin resistance. There was, however, no significant association of diabetes with SAD in male nor in female patients.
CONCLUSIONS: Our results showed that diabetes is associated with the frequency of intracranial LAD, especially in males. Out study may be regarded as evidence of differential biological effects of diabetes on cerebral vasculature.

Entities:  

Mesh:

Year:  2008        PMID: 18537055     DOI: 10.1007/s00415-008-0864-0

Source DB:  PubMed          Journal:  J Neurol        ISSN: 0340-5354            Impact factor:   4.849


  39 in total

1.  Serum C-reactive protein concentration and genotype in relation to ischemic stroke subtype.

Authors:  Claes Ladenvall; Katarina Jood; Christian Blomstrand; Staffan Nilsson; Christina Jern; Per Ladenvall
Journal:  Stroke       Date:  2006-06-29       Impact factor: 7.914

2.  Risk factors for ischemic stroke subtypes: the Atherosclerosis Risk in Communities study.

Authors:  Tetsuya Ohira; Eyal Shahar; Lloyd E Chambless; Wayne D Rosamond; Thomas H Mosley; Aaron R Folsom
Journal:  Stroke       Date:  2006-08-24       Impact factor: 7.914

Review 3.  Race, sex and occlusive cerebrovascular disease: a review.

Authors:  L R Caplan; P B Gorelick; D B Hier
Journal:  Stroke       Date:  1986 Jul-Aug       Impact factor: 7.914

4.  Acute cerebrovascular disease in women.

Authors:  A Arboix; M Oliveres; L García-Eroles; C Maragall; J Massons; C Targa
Journal:  Eur Neurol       Date:  2001       Impact factor: 1.710

5.  Capsular infarcts: the underlying vascular lesions.

Authors:  C M Fisher
Journal:  Arch Neurol       Date:  1979-02

6.  MR signal abnormalities at 1.5 T in Alzheimer's dementia and normal aging.

Authors:  F Fazekas; J B Chawluk; A Alavi; H I Hurtig; R A Zimmerman
Journal:  AJR Am J Roentgenol       Date:  1987-08       Impact factor: 3.959

7.  Race-ethnicity and determinants of intracranial atherosclerotic cerebral infarction. The Northern Manhattan Stroke Study.

Authors:  R L Sacco; D E Kargman; Q Gu; M C Zamanillo
Journal:  Stroke       Date:  1995-01       Impact factor: 7.914

8.  The role of lifestyle factors in the etiology of stroke. A population-based case-control study in Perth, Western Australia.

Authors:  K Jamrozik; R J Broadhurst; C S Anderson; E G Stewart-Wynne
Journal:  Stroke       Date:  1994-01       Impact factor: 7.914

9.  Classification of subtype of acute ischemic stroke. Definitions for use in a multicenter clinical trial. TOAST. Trial of Org 10172 in Acute Stroke Treatment.

Authors:  H P Adams; B H Bendixen; L J Kappelle; J Biller; B B Love; D L Gordon; E E Marsh
Journal:  Stroke       Date:  1993-01       Impact factor: 7.914

10.  Sex differences in first-ever acute stroke.

Authors:  Jaume Roquer; Ana Rodríguez Campello; Meritxell Gomis
Journal:  Stroke       Date:  2003-06-12       Impact factor: 7.914

View more
  7 in total

1.  Heterogeneity of single small subcortical infarction can be reflected in lesion location.

Authors:  Lulu Wen; Juan Feng; Dongming Zheng
Journal:  Neurol Sci       Date:  2012-09-14       Impact factor: 3.307

2.  Atherosclerosis in intracranial or extracranial vessels in diabetic patients and the association with stroke subtype.

Authors:  Li-Ming Wei; Yue-Qi Zhu; Yu-Qian Bao; Hai-Tao Lu; Pei-Lei Zhang; Yu-Wu Zhao; Mei Li; Jun-Gong Zhao
Journal:  Quant Imaging Med Surg       Date:  2019-06

3.  Dynamic temporal change of cerebral microbleeds: long-term follow-up MRI study.

Authors:  Seung-Hoon Lee; Soon-Tae Lee; Beom Joon Kim; Hee-Kwon Park; Chi-Kyung Kim; Keun-Hwa Jung; Jae-Kyu Roh
Journal:  PLoS One       Date:  2011-10-11       Impact factor: 3.240

Review 4.  Cerebral microbleeds: their associated factors, radiologic findings, and clinical implications.

Authors:  Beom Joon Kim; Seung-Hoon Lee
Journal:  J Stroke       Date:  2013-09-27       Impact factor: 6.967

5.  HCV, but not HIV, is a risk factor for cerebral small vessel disease.

Authors:  Susan Morgello; Jacinta Murray; Sarah Van Der Elst; Desiree Byrd
Journal:  Neurol Neuroimmunol Neuroinflamm       Date:  2014-09-04

6.  Prognosis and antiplatelet therapy of small single subcortical infarcts in penetrating artery territory: a post hoc analysis of the Third China National Stroke Registry.

Authors:  Yu-Yuan Xu; Jing Jing; Yi-Jun Zhang; An-Xin Wang; Zi-Xiao Li; Li-Ping Liu; Xing-Quan Zhao; Yi-Long Wang; Hao Li; Xia Meng; Yong-Jun Wang
Journal:  BMJ Neurol Open       Date:  2022-04-05

7.  Combined effects of type 2 diabetes and hypertension associated with cortical thinning and impaired cerebrovascular reactivity relative to hypertension alone in older adults.

Authors:  Ekaterina Tchistiakova; Nicole D Anderson; Carol E Greenwood; Bradley J MacIntosh
Journal:  Neuroimage Clin       Date:  2014-06-05       Impact factor: 4.881

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.